ArticleBMJ case reports2019

High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.

Marie Lind-Holst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.